Abstract. Acute cerebral infarction can progress rapidly, and there are limited specific and effective treatments. Small ubiquitin-like modifiers (SUMOs) provide an important post-translational modification of proteins. Following cerebral infarction, multiple proteins can combine with SUMOs to protect nerve cells. Furthermore, moderate hypothermia (core body temperature, 33-34˚C) can increase the level of SUMOylation on multiple proteins. In the present study, it was examined whether moderate hypothermia increases the survival rate of bone marrow stromal stem cells (BMSCs) implanted in the cerebral ischemic penumbra via SUMOylation of multiple proteins. Firstly, BMSCs were exposed to oxygen-glucose deprivation (OGD) under moderate hypothermic (33˚C) conditions. Subsequently, adult rats with middle cerebral artery occlusion were treated with a combination of BMSCs and moderate hypothermia (32-34˚C). The results demonstrated that hypothermia promoted the combination of multiple proteins with SUMOs in BMSCs, and induced transport of SUMOs from the cytoplasm to the nucleus. Moderate hypothermia additionally reduced damage to BMSCs following OGD and improved BMSC survival following transplantation into the penumbra. These data suggest that moderate hypothermia may protect against BMSC injury via rapid SUMOylation of intracellular proteins. Thus, BMSC transplantation combined with moderate hypothermia may be a potential therapeutic strategy to treat cerebral infarction.
Introduction
Cerebrovascular ischemia is challenging to treat due to its rapid progression, and there are a limited number of effective treatments. The resulting cerebral infarction can cause severe sequelae in patients and markedly affects quality of life (1) . The penumbral areas around the main cerebral lesions contain numerous dormant or semi-dormant brain cells that can only maintain their integrity, rather than perform their normal function, as a result of reduced energy and oxygen supply (2) . The protection of these cells is important for clinical treatment of infarction (3) . Bone marrow stromal cells (BMSCs) are skeletal progenitor cells that can differentiate into bone, cartilage, fat and nerve cells (4, 5) . BMSCs are easy to acquire, expand, genetically manipulate and transplant in vivo, and are becoming increasingly used in the field of neural regeneration and transplantation (6) .
Moderate hypothermia is well recognized to protect the brain from hypoxic-ischemic injury, potentially via reducing the cerebral metabolic rate of oxygen and lowering the synthesis and release of excitotoxic neurotransmitters and inflammatory mediators (7, 8) . The penumbral region of the brain is an ischemic, hypoxic, inflammatory and toxic environment, which limits stem cell transplantation into the penumbra due to their reduced survival and proliferation, in addition to premature aging (9) (10) (11) . The combination of neural stem cell transplantation into the penumbra and moderate hypothermia may provide an improved treatment regime for ischemic stroke (12) . However, the molecular mechanisms of protection by the combination neural stem cells and hypothermia remain unclear. Understanding these mechanisms is important to provide more effective and rational clinical treatments involving moderate hypothermia.
Small ubiquitin-related modifiers (SUMOs) are an important class of post-translational modification protein factors and involved in maintaining genome stability (13) , protein-protein interactions, translocation between the cytoplasm and nucleus, and limiting ubiquitination by combining with target proteins (14, 15 Cell culture. Methods for the extraction and culture of BMSCs have been described previously (4, 19) . Briefly, the long bones of the hind legs were dissected from the two newborn male rats, and bone marrow plugs were extracted from the bones by flushing the bone marrow cavity with complete culture medium (RASMX-90011, Cyagen Biosciences Inc. Santa Clara, CA, USA). About 5x10 7 cells were seeded in a 75-cm 2 culture flask and incubated at 37˚C in a humidified atmosphere with 5% CO 2 . Non-adherent cells were removed after 24 h, and the culture medium was replaced every 3 days. Adherent cells reached 90-95% confluence within 10-15 days and were passaged with 0.25% trypsin (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) at a ratio of 1:3. Cells at passage 3 were characterized by flow cytometry (Abcam, Shanghai, China).
Oxygen-glucose deprivation model and moderate hypothermic therapy. To simulate cerebral ischemia, BMSCs were cultured in an anoxic chamber (Forma Scientific Anaerobic System; Thermo Fisher Scientific, Inc.) (20) . Glucose-, L-aspartic acid-, L-glutamic acid-, and sodium pyruvate-free neurobasal medium (Gibco; Thermo Fisher Scientific, Inc.) was equilibrated overnight in the anoxic chamber with the anoxic gas mixture (85% N 2 , 10% H 2 and 5% CO 2 ). Cultured cells were washed three times with the anoxic medium and then transferred to the anoxic chamber. Following 60 min of oxygen-glucose deprivation (OGD), the anoxic medium was replaced with neurobasal/B27 medium, and the cells were transferred to incubators set at 33˚C or 37˚C with a gas mixture of 95% air and 5% CO 2 for an additional 24 h. The neurobasal/B27 medium was pre-warmed to 33˚C or 37˚C for induction of moderate hypothermia. Western blot analysis. To avoid de-SUMOylation of proteins during sample preparation, BMSCs were homogenized in ice-cold RIPA lysis buffer (EMD Millipore, Billerica, MA, USA). The cell lysates were centrifuged at 17,970 x g for 15 min at 4˚C. The supernatant was collected, and protein concentrations were measured using a bicinchoninic acid assay kit (Thermo Fisher Scientific, Inc.). Samples were mixed with sample buffer (Invitrogen; Thermo Fisher Scientific, Inc.), incubated at 70˚C for 10 min, and then applied to sodium dodecyl sulfate polyacrylamide gel electrophoresis (4-15% gels; Invitrogen; Thermo Fisher Scientific, Inc.) with 30 µg total protein added per well. Subsequent to electrophoresis, the proteins were transferred to polyvinylidene fluoride membranes (EMD Millipore). The membranes were blocked in a Tris-HCl-buffered salt solution containing 0.1% Tween-20 (TBST) and 5% skimmed milk powder, and then incubated with anti-SUMO1 (1:1,000), anti-SUMO2/3 (1:1,000), or anti-UBC9 (cat. no. 4786; 1:1,000; Cell Signaling Technology, Inc., Danvers, MA, USA) antibodies overnight at 4˚C. Then, the membranes were washed five times with TBST, followed by incubation with horseradish peroxidase-conjugated goat anti-rabbit IgG (111-035-003; 1:2,000; Jackson Immuno Research Laboratories, Inc., West Grove, PA, USA) as the secondary antibody for 1 h at room temperature. Following five washes with 0.1% TBST, proteins were detected using a C-Digit Blot Scanner (LI-COR Biosciences, Lincoln, NE, USA). The membrane was then stripped and re-incubated with an anti-β-actin primary antibody (cat. no. 3700; 1:1,000; Cell Signaling Technology, Inc. under a fluorescence microscope (Olympus Corporation, Tokyo, Japan). The total number of cells (Hoechst-positive) and the number of apoptotic cells (TUNEL-positive) were quantified. The apoptotic rate (%) was calculated by the number of apoptotic cells/the number of total cells x100%.
Lactate dehydrogenase (LDH) activity detection. After harvesting the BMSCs, LDH content in the culture media was measured by an enzyme-linked immunosorbent assay (LDH Activity Assay kit; BioVision, Inc., San Francisco, CA, USA) according to the manufacturer's protocols.
Rat middle cerebral arter y occlusion model and moderate hypothermic treatment. A total of 40 adult male Sprague-Dawley rats were randomly divided into four groups. For surgery, animals were maintained by a small animal ventilator (Shanghai Yuyan Instruments Co., Ltd., Shanghai, China), and rectal temperature was monitored to control body temperature. A 1 cm longitudinal incision was made between the sternum and mandible, the left common carotid artery was isolated, external carotid and internal carotid arteries were visualized under a microscope (Olympus Corporation), the proximal heart end of the carotid artery and distal heart end of the external carotid artery were ligated, and a nylon suture (head-end diameter, 0.23 mm; trunk diameter, 0.18 mm) was inserted from the carotid artery into the middle cerebral artery (~12.0 mm deep) and fixed with a suture.
BMSCs or SiUBC9 BMSCs were transplanted into the ischemic penumbra after establishment of the middle cerebral artery occlusion (MCAO) models as reported pre viously (12, 21, 22) . To induce moderate hypothermia, rats transplanted with BMSCs were placed on a hypothermia blanket (Shanghai Yuyan Instruments Co., Ltd.), and a rectal temperature monitor was used to control body temperature at 32-34˚C for 12 h. The animals were then removed from anesthesia and gradually returned to normal body temperature. Animals were recovered for 2, 7, 14 or 21 days, and neurological functions were assessed by neurological severity scores (NSSs) (23, 24) .
Statistics analysis. All experiments were repeated at least three times. Data are expressed as the mean ± standard error. Statistical software (GraphPad Prism 6; GraphPad Software, Inc., La Jolla, CA, USA) was used for all statistical tests. Comparisons between multiple groups were evaluated by one-way analysis of variance, and comparisons between two groups were evaluated by Student's unpaired t-test. P<0.05 was considered to indicate a statistically significant difference.
Results

Moderate hypothermia promotes SUMO1 and SUMO2/3 binding to target proteins and induces SUMO translocation from the cytoplasm to the nucleus in BMSCs.
BMSCs extracted from rats were cultured in conditioned medium and identified by flow cytometry. The results indicated high levels of expression of BMSC-specific proteins CD71 and CD105, however no expression of hematopoietic stem cell-specific proteins CD34 and CD45 (Fig. 1A) . BMSCs were then cultured at 33˚C for 0-48 h and used to detect expression of SUMO1 and SUMO2/3. There was a trend towards a slow increase in expression of free SUMO1 conjugates up to 24 h after moderate hypothermia (33˚C), a significant decrease after 24 h, and a marginal increase at 48 h. It was suggested that, following 36-48 h of moderate hypothermia, production of new free SUMO1 may exert cytoprotective effects (Fig. 1B and C) . In contrast, short term treatment of BMSCs with moderate hypothermia (<2 h) induced a trend towards an increase in combined SUMO2/3 expression, which peaked at 24-36 h, and then remained elevated after 36 h (Fig. 1D and  E) . BMSCs cultured under moderate hypothermia for 2 or 24 h also presented with marked translocation of SUMO1 and SUMO2/3 from the cytoplasm to the nucleus (SUMO1 at 24 h and SUMO2/3 at 2 h; Fig. 1E and F) .
SiUBC9 inhibits SUMO binding to target proteins in BMSCs under hypoxia.
UBC9 is the SUMO-conjugating enzyme E2 that acts on inactive SUMOs to induce SUMOylation of substrates together with the SUMO-activating enzyme E1, SUMO ligase E3, and adenosine triphosphate (25) . In the present study, BMSCs were cultured under OGD to simulate hypoxia-ischemia. Using RNA interference in BMSCs, expression of UBC9 was significantly reduced compared with wild-type (WT) and SiNC BMSCs ( Fig. 2A and B) . Following OGD, expression of SUMO conjugates and free SUMOs was significantly stimulated in WT and SiNC BMSCs. Conversely, in UBC9 knockdown BMSCs, SUMO1 and SUMO2/3 conjugates were reduced significantly, while the level of free SUMOs was significantly increased under normal and OGD culture conditions (Fig. 2C-F) .
Moderate hypothermia causes SUMOylation-dependent reductions in BMSC apoptosis and LDH secretion following hypoxia. WT and SiNC BMSCs cultured at 33˚C following OGD exhibited significant decreases in apoptosis and LDH secretion compared with those cultured at 37˚C. However, UBC9 knockdown BMSCs exhibited no resistance against moderate hypothermia (Fig. 3A and B) . Thus, a lack of UBC9 hinders SUMO binding to target proteins, it is speculated that the protective effect of moderate hypothermia may be associated with intracellular protein SUMOylation. Notably, down-regulation of UBC9 expression was additionally observed in BMSCs under normal culture conditions, which was associated with an increase in BMSC apoptosis and LDH release, suggesting a role of protein SUMOylation in the maintenance of cellular functions and resistance. These results indicated that knockdown of UMBC9 reduced the binding ability of SUMOs to target proteins and suppressed the cytoprotective effect.
Moderate hypothermia causes SUMOylation-dependent improvements in survival of BMSCs transplanted into the ischemic penumbra. WT and SiUBC9
BMSCs were transplanted into the penumbra of MCAO model rats that were then subjected to moderate hypothermia. There was a progressive reduction in neurological function as assessed by the NSSs of MCAO animals without BMSC transplantation or moderate hypothermia. In contrast, MCAO rats with BMSC transplantation had improved neurological functions, whereas animals with BMSC transplantation combined with moderate hypothermia showed further improvements. However, the improvement in neurological functions of MCAO rats that received transplantations of BMSCs with UBC9 knockdown following moderate hypothermia was less than that in animals transplanted with BMSCs at 33˚C (Table I ). These data suggest that transplantation of BMSCs into the penumbra improves neurological function following MCAO, and that moderate hypothermia increases the activity and survival of transplanted BMSCs and promotes functional recovery, potentially via increased intracellular protein SUMOylation.
Discussion
There has been a progressive increase in the incidence of cerebral infarction due to the increasing rates of diabetes, hypertension, and high cholesterol in the general population. Early interventional therapy is an effective treatment for cerebral ischemia. However, the majority of patients are not treated within this time window, resulting in serious sequelae. Thus, new treatments are urgently required, which are effective outside of this time window. BMSCs are skeletal progenitor cells that are easy to obtain, expand in vitro, and transplant in vivo. Previous studies have demonstrated that BMSCs can be differentiated into bone, cartilage, fat and nerve cells, and that BMSCs may be neuroprotective (26) (27) (28) . Thus, transplantation of BMSCs into the infarction area and subsequent differentiation into neuronal cells may provide a novel treatment for cerebral infarction. However, the hypoxic-ischemic environment in brain tissue following infarction can markedly reduce the survival of transplanted cells (29) .
SUMOs are a class of important ubiquitin-like proteins. There are four SUMO family members that have been identified in humans (SUMO1-4), by contrast, the SUMO-conjugating enzyme E2 has only one form (UBC9), and RNA interference knockdown of UBC9 expression can effectively block SUMOylation of intracellular proteins (30) . SUMOs have both free and conjugate forms that maintain the balance of cellular SUMOylation. Protein SUMOylation serves an important role in maintenance of genomic stability, regulation of protein interactions, nuclear/cytoplasmic translocation, transcription factor activity, and inhibition of protein biotinylation. Notably, proteomic studies have identified that, following cerebrovascular ischemia, numerous proteins closely associated with physiological and pathological processes, including oxidative stress, inflammation, DNA synthesis, energy transfer and metabolism, are SUMOylated, which may aid in the removal of foreign material, reduce inflammatory responses, and regulate cellular proliferation and apoptosis (31, 32) . In addition, it was observed that SUMO2/3 are neuroprotective and improve behavioral outcomes following experimental cerebral ischemia (17, 33) .
Moderate hypothermic treatment is an effective therapy for treatment of high intracranial pressure and brain injury caused by severe hypoxia-ischemia. Hypothermia reduces the cellular metabolic rate, increases energy reserves to allow cellular recovery, reduces the inflammatory response and improves the brain microenvironment (34) . In the present study, the association between moderate hypothermic treatment and protein SUMOylation was observed in BMSCs following hypoxia-ischemia. It was identified that conjugated SUMO2/3 were rapidly and highly induced in BMSCs subsequent to moderate hypothermic treatment, while free SUMO2/3 were decreased with marked SUMO2/3 nuclear translocation. These data suggest that the protective actions of moderate hypothermia are associated with the binding of SUMO2/3 to target proteins, rather than the initial expression of SUMO2/3 (35) . In contrast, there was slow and low level SUMOylation of target proteins by SUMO1 with only moderate nuclear translocation. Further studies are required to determine the specific target proteins that combine with SUMOs and their biological functions in the SUMOylation pathway.
It was observed that the levels of conjugated SUMO1 and SUMO2/3, in addition to their nuclear translocation, were progressively increased in BMSCs following OGD treatment (SUMO2/3 within 2 h and SUMO1 from 24-48 h). Similar results have been reported previously (33) . The rate of BMSC apoptosis and LDH secretion induced by OGD treatment were also reduced by moderate hypothermic treatment. Furthermore, these effects disappeared following UBC9 knockdown in BMSCs, which blocks the binding of SUMOs to their target proteins (36) . Finally, the effects of BMSCs, moderate hypothermia and combination therapy on the recovery of neurological function in MCAO rats were investigated. Results indicated that transplantation of BMSCs into the ischemic penumbra in MCAO rats combined with moderate hypothermia was optimal for restoring neurological function. Furthermore, this protection was SUMOylation-dependent, explained by the fact that the improvement in neurological function in MCAO rats receiving transplantation of BMSCs with UBC9 knockdown following moderate hypothermia had a reduced quality of neurological function than animals transfected with BMSCs at the same temperature.
In summary, moderate hypothermia significantly enhances the ability of SUMOs to bind to their target proteins in BMSCs, suggesting an important role in regulating cellular apoptosis and functions following hypoxia-ischemia. Thus, moderate hypothermia promotes neural stem cell survival in the ischemic penumbra by increasing SUMOylation of multiple proteins. The results provide a further understanding of the molecular mechanisms underlying the protective actions of moderate hypothermia, and provide a theoretical basis for the use of bone marrow stem cell transplantation combined with moderate hypothermia for treatment of cerebral infarction.
